GSTK1
Glutathione S-transferase kappa 1
Also known as: GST13, GSTK1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2Q3
- Gene
- GSTK1
- Ensembl
- ENSG00000197448
- Chromosome
- 7
- Canonical length
- 226 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Peroxisomes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the kappa class of the glutathione transferase superfamily of enzymes that function in cellular detoxification. The encoded protein is localized to the peroxisome and catalyzes the conjugation of glutathione to a wide range of hydrophobic substates facilitating the removal of these compounds from cells. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
226 residues, UniProt reviewed canonical sequence.
>Q9Y2Q3|GSTK1
1 MGPLPRTVEL FYDVLSPYSW LGFEILCRYQ NIWNINLQLR PSLITGIMKD SGNKPPGLLP
61 RKGLYMANDL KLLRHHLQIP IHFPKDFLSV MLEKGSLSAM RFLTAVNLEH PEMLEKASRE
121 LWMRVWSRNE DITEPQSILA AAEKAGMSAE QAQGLLEKIA TPKVKNQLKE TTEAACRYGA
181 FGLPITVAHV DGQTHMLFGS DRMELLAHLL GEKWMGPIPP AVNARLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GSTK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 427 nTPM
Expression across tissuesHPA
Tissue
- liver: 427 nTPM
- choroid plexus: 342 nTPM
- tongue: 302 nTPM
- duodenum: 298 nTPM
- parathyroid gland: 289 nTPM
- small intestine: 261 nTPM
Single-cell type
- late spermatids: 1,578 nCPM
- early spermatids: 664 nCPM
- enterocytes: 588 nCPM
- hepatocytes: 370 nCPM
- hofbauer cells: 359 nCPM
- cytotrophoblasts: 356 nCPM
Immune cell
- total PBMC: 917 nTPM
- T-reg: 803 nTPM
- non-classical monocyte: 645 nTPM
- intermediate monocyte: 599 nTPM
- memory CD4 T-cell: 556 nTPM
- classical monocyte: 538 nTPM
Brain region
- choroid plexus: 185 nTPM
- white matter: 70 nTPM
- medulla oblongata: 68 nTPM
- midbrain: 65 nTPM
- thalamus: 64 nTPM
- pons: 61 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thioredoxin-like superfamily
- DSBA-like thioredoxin domain
- HCCA isomerase/glutathione S-transferase kappa
- Glutathione S-transferase kappa
- Glutathione S-transferase Kappa/NadH
- DSBA-like thioredoxin domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GSTK1 as an antibody target. Whether an autoantibody or antibody against GSTK1 could matter depends on whether native GSTK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GSTK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GSTK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...